Inside Washington: Crisis and Costs Grip Biotech Industry

Publication
Article
BioPharm InternationalBioPharm International-10-01-2001
Volume 14
Issue 10

by Jill Wechsler Terrorist attack may postpone health policy legislation but encourage antibioterrorism initiatives.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Recent Videos
Junevity Co-founder & CEO, John Hoekman, PhD
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Daniel Fischer, Tevard
Related Content
© 2025 MJH Life Sciences

All rights reserved.